LG Chem Ltd. manufactures petrochemicals, IT & electronic materials and energy solution materials. It operates through through the following business segments: Petrochemicals, IT & Electronic Materials, Batteries. The Petrochemical division offers naphtha cracking centers and polyolefins, synthetic rubbers and specialty polymers, polyvinyl chloride, acrylonitrile-butadiene-styrene and engineering plastics, acrylates and plasticizers. The IT & Electronic Material division provides optical and display materials namely polarizers, phosphors, organic light emitting diode, photosensitive materials for liquid crystal display; printed circuit materials such as flexible materials, halogen free materials, integrated circuit packaging materials, epoxy resin system materials, high speed materials and build-up materials; toners such as color toners, black laser printer toners and black copier toners. The Battery division provides lithium-ion cylindrical batteries, lithium-ion polymer batteries, lithium-ion prismatic batteries, medium and large batteries. The company was founded in January 1947 and is headquartered in Seoul, South Korea.

Nippon Shokubai Co., Ltd. engages in the manufacture and sale of industrial chemicals and catalysts. It operates through the following segments: Basic Chemicals, Functional Chemicals, and Environment & Catalysts. The Basic Chemicals segment offers acrylic acid, acrylic ester, ethylene oxide, glycol, ethanolamine, higher alcohol surfactant, and glycol ether. The Functional Chemicals segment covers super-absorbent polymers, pharmaceutical intermediates, polymers for concrete admixture, electronic and information materials, iodine, maleic anhydride, resins for paints and adhesives, plastic molded products, and processed adhesive materials. The Environment & Catalysts segment deals with exhaust gas treatment equipment, fuel cell materials, and catalysts. The company was founded on August 21, 1941 and is headquartered in Osaka, Japan.

Lyondell Chemical Technology LP, part of LyondellBasell Industries NV, is a company headquartered in the United States. The firm manufactures and markets intermediate chemicals and performance chemical products.

Gotec SA is a Swiss private company located in Sion. The firm develops, manufactures and sells solenoid, heating oil, condensate & rotary vane pumps.

SABIC Global Technologies BV is a company headquartered in Bergen op Zoom, the Netherlands and ultimately controlled by the Government of Saudi Arabia. The firm produces petrochemicals, polymers, fertilizers and other basic chemicals.

Explores petroleum and natural gas

Huntsman Specialty Chemicals Corp., a subsidiary of Huntsman Corp., is an American company involved in industrial organic chemicals.

UOP LLC operates as a supplier and technology licensor for the petroleum refining, gas processing and petrochemical production. Its products include catalysts and adsorbents. The firm offers design, commissioning, ongoing operations, and optimization services. The company was founded on June 17, 1914 and is headquartered in Des Plaines, IL.

Crompton Corporation is a global producer and marketer of specialty chemicals and polymer products. Products and services solve customer problems and add value to customers' products.Crompton, formed by the merger of Crompton & Knowles and Witco, isn't mixed-up, but its products are. The company gets three-fourths of its sales from producing polymers; polymer additives, including additives for plastics, rubber, and urethane; and polymer processing equipment. Crompton agreed to acquire Great Lakes Chemical in early 2005

Chemtura Corporation, with 2011 revenues of $3 billion, is a global specialty chemicals company with products in the transportation, energy & electronis, and agriculture markets. Chemtura was formed in 2005 when Crompton Corporation joined with Great Lakes Chemical Corporation. Our history – which includes Crompton & Knowles Corporation, Uniroyal Chemical Corporation and Witco Corporation – reflects more than 100 years of growth and innovation. Chemtura has approximately 4,200 employees in research, manufacturing, sales and administrative facilities in every major market of the world. We are a leading global supplier of plastic additives, including flame retardants; a leading manufacturer of pool and spa products; a global leader in seed treatment and miticides in the agricultural market; the largest component supplier to the lubricants industry; and a top global producer of urethane polymers. At Chemtura, our focus is on excellence in everything we do, and performance improvement is our mission: for our customers who seek business solutions; for our employees who want to grow and learn; and for investors who look for innovative thinking, strong planning and solid results. Chemtura’s vision is to create sustainable competitive advantage for our customers by combining our experience and expertise in cutting-edge technologies with a deep understanding of their end-use applications, making us an indispensable partner in solving their toughest problems.

Mitsubishi Gas Chemical Co., Inc. engages in the manufacture and sale of organic and inorganic chemicals, petroleum-derived chemicals, and its related products. It operates through the following segments: Natural Gas Chemicals, Aromatic Chemicals, Functional Chemicals, Specialized Functional Materials, and Others. The Natural Gas Chemicals segment produces and sells methanol, ammonia, amines, methacrylate, polyol, enzyme, functional food materials, and crude oil. The Aromatic Chemicals segment engages in the manufacture and sale of xylene isomers and xylene derivatives. The Functional Chemicals segment deals with the production and sale of industrial inorganic chemicals, electronic chemicals, and engineering plastics. The Specialized Functional Materials segment manufactures and sells printed circuit boards and oxygen absorbers. The Others segment covers the real estate business. The company was founded on January 15, 1918 and is headquartered in Tokyo, Japan.

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. It has a global partnership with Roche for developing novel CRACM inhibitors, an oral calcium released activated calcium modulator ion channel inhibitor program that is in the lead optimization stage for the treatment of autoimmune diseases. The company also retains rights in various indications and markets to its other drug candidates and programs, which include STA-9090, an Hsp90 inhibitor that is in Phase 1 development; elesclomol, an oxidative stress inducer for the treatment of cancer; and apilimod, an oral IL-12/23 inhibitor, which is in Phase 2 for rheumatoid arthritis. In addition, Synta Pharmaceuticals Corp. is developing STA-9584, a vascular disrupting agent that is in preclinical development. The company was incorporated in 2000 and is based in Lexington, Massachusetts.

Zeneca is a British multinational pharmaceutical company focused on therapeutic oncology and cardiovascular products. Zeneca was established in June 1993 through a demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries. In 1999 Zeneca and Astra AB, a Sweden-based pharmaceutical company, merged to form AstraZeneca plc.

Wuhan Top Resources Holdings Co., Ltd., established on 2019-09-24, Scope of business includes mining of minerals(branch only);metal ore sales;Inspection and testing service;lubricating oil,petrochemical products(Excluding chemical hazards)promotion of;Operating without storage facilities(No physical display business premises):gasoline,diesel fuel[Closed cup flash point ≤60ºC],kerosene,Methanol,1,2-Xylene,1,3-Xylene,1,4-Xylene,Mixture of xylene isomers,crude oil,naphtha,methyl tert-butyl ether,petroleum ether,Isooctane,n-pentane,ethanol[Anhydrous],Isobutane,Methanol gasoline,liquefied petroleum gas(Only for industrial raw material use,Does not include town gas),natural gas[rich in methane](Only for industrial raw material use,Does not include town gas);Import and export,Technology Import and Export,Agent import and export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state).(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Anhui Haide Chemical Technology Co., Ltd., established on 2009-08-21, Business scope includes research and development of organic chemical raw materials;112400Ton/Low Olefin Liquefied Gas,80000Ton/Aromatic oil,135840Ton/MTBE,1500Ton/Annual Methanol Recovery and Production;160700Ton/Annual Industrial Isooctane,12300Ton/Propane,28700Ton/n-butane,4577Ton/year98%sulfuric acid,3000Nm³Hydrogen production process system;Propylene,butane,Butene,Isobutylene,sulfuric acid,Butadiene,methyl tert-butyl ether,carbon four,carbon five,carbon nine,Mixed aromatics,liquefied petroleum gas(industrial use),naphtha,Solvent oil,Methanol,ethanol,Propane Wholesale;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

AstraZeneca is an innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in healthcare. AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines that are innovative, effective, and which offer added benefits such as reduced side effects or better ways of taking the treatment. AstraZeneca focuses on getting the best from every medicine they make by exploring all the ways it can be used or improved. AstraZeneca was established on April 6, 1999, in Cambridgeshire, United Kingdom.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.